Stay updated with breaking news from Research Models. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Charles River Laboratories International, Inc. (NYSE:CRL – Get Rating) has been assigned a consensus rating of “Moderate Buy” from the fourteen analysts that are covering the company, MarketBeat Ratings reports. Three research analysts have rated the stock with a hold rating and five have assigned a buy rating to the company. The average 12-month price […]
Did you lose money on investments in Charles River? If so, please visit Charles River Laboratories International, Inc. Shareholder Class Action Lawsuit or contact Peter Allocco... | May 24, 2023
Did you lose money on investments in Charles River? If so, please visit Charles River Laboratories International, Inc. Shareholder Class Action Lawsuit or...
StockNews.com began coverage on shares of Charles River Laboratories International (NYSE:CRL – Get Rating) in a research report issued on Thursday. The brokerage set a “hold” rating on the medical research company’s stock. Several other equities research analysts also recently commented on CRL. Wells Fargo & Company cut their target price on shares of Charles […]
Artisan Partners Limited Partnership decreased its stake in shares of Charles River Laboratories International, Inc. (NYSE:CRL – Get Rating) by 18.8% in the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 15,258 shares of the medical research company’s stock after selling 3,534 shares during […]